News and Activities

Sikarin Public Company Limited (“the Company”) reported its performance for the first quarter of 2025, with total operating revenue reaching 1,532 billion Baht and a net profit of 207 million Baht. The Company aims to enhance the potential of the Center of Excellence to boost growth, emphasizing that total revenue for 2025 is on track to reach the target of 6.5 billion Baht.

Mr. Suriyan Kojonroj, Deputy Managing Director and Chief Operating Officer of Sikarin Public Company Limited (“SKR”), revealed the performance results for the first quarter of 2025, stating that amid surrounding risk factors, especially challenges from economic factors both domestically and internationally due to the tensions of the trade war, the economy has a high level of uncertainty. However, overall, the Company has still managed to maintain its revenue growth from overall operations at a level close to last year’s 1,532 million Baht.

According to the growth of revenue from healthcare services for the general customer group, which increased by 1.12% compared to the same period last year, amounting to 910 million Baht, due to the acceleration of enhancing medical capabilities through 7 leading medical institutes, including the Orthopedic Institute, Heart Institute, Vascular and Stroke Institute, Pediatrics Institute, Women's Health Institute, GI and Scope Institute, and Emergency Medicine Institute.

While the revenue from healthcare for social security customers has decreased slightly by about 3% from the same period last year to 575 million Baht, the main reason is the reduction in the treatment of complex diseases requiring surgery from social security customers through the MOU project, which has been reduced from 5 disease groups to 2 disease groups, namely coronary artery disease and cerebrovascular disease. Meanwhile, the revenue from mobile hospital services (SIKARIN Connect) amounted to over 26 million Baht.

For operating expenses including depreciation for the first quarter of 2025, there is a slight increase of about 2% from the same period last year, totaling approximately 1,263 million Baht, driven primarily by cost of medical treatment, which are at 1,044 million Baht due to medical fees and medical personnel expenses. However, selling and administrative expenses decreased by nearly 4% to 213 million Baht, resulting in the Company having a net profit of 207 million Baht.

"For the trend in the second quarter and the second half of 2025, the Company is preparing to accelerate the development of specialized medical institutes to enhance treatment capabilities and improve the experience of Social Security patients through the SSO Plus project, while expanding mobile hospital services nationwide under the Sikarin Connect project to become a leading hospital in managing complex diseases in Thailand. This will drive total revenue growth of 6.5 billion Baht for the year 2025, maintaining a net profit margin of 12 - 15% to create long-term returns for shareholders," Mr. Suriyan said.

Source: กรุงเทพธุรกิจ